Skip to main content
Published locations for First-Line Pembrolizumab Therapy in a Cisplatin-Ineligible Patient With Plasmacytoid Urothelial Carcinoma: A Case Report
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
First-Line Pembrolizumab Therapy in a Cisplatin-Ineligible Patient With Plasmacytoid Urothelial Carcinoma: A Case Report
User login
Username
Password
Reset your password
/content/first-line-pembrolizumab-therapy-cisplatin-ineligible-patient-plasmacytoid-urothelial
/fedprac/avaho/article/174546/colon-and-rectal/first-line-pembrolizumab-therapy-cisplatin-ineligible